| 1 |
matrix metalloproteinase-9
(6055 times)
|
Neoplasms
(772 times)
|
VEGF (384 times)
TIMP-1 (376 times)
TNF-alpha (358 times)
|
1992 Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9.
|
| 2 |
matrix metalloproteinase-9, gelatinase B
(4 times)
|
Molecular Biology
(2 times)
|
ELISA (1 time)
IA (1 time)
OA (1 time)
|
1996 Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
|
| 3 |
metallomatrix proteinase-9
(3 times)
|
Biocompatible Materials
(1 time)
|
APP (1 time)
BA (1 time)
CAT (1 time)
|
2008 Transgelin: an actin-binding protein and tumour suppressor.
|
| 4 |
migration marker proteins matrix metalloproteinase-9
(2 times)
|
Neoplasms
(2 times)
|
BAMBI (1 time)
ESCC (1 time)
HAS1 (1 time)
|
2017 HNF1A‑AS1 promotes growth and metastasis of esophageal squamous cell carcinoma by sponging miR‑214 to upregulate the expression of SOX-4.
|
| 5 |
MMP-9KO
(2 times)
|
Medicine
(1 time)
|
MMP-2 (3 times)
WT (2 times)
AAA (1 time)
|
2002 Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms.
|
| 6 |
(CypA)-Matrix metallopeptidase-9
(1 time)
|
Molecular Biology
(1 time)
|
APOE (1 time)
BBB (1 time)
CypA (1 time)
|
2018 Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury.
|
| 7 |
makes measurement of salivary metalloproteinase-9
(1 time)
|
Dentistry
(1 time)
|
AUC (1 time)
IQR (1 time)
OSCC (1 time)
|
2017 Salivary MMP-9 in the detection of oral squamous cell carcinoma.
|
| 8 |
matrix and secrete high levels of 92-kd metalloproteinase
(1 time)
|
Allergy and Immunology
(1 time)
|
HIV (1 time)
|
1995 Interferon-gamma inhibits HIV-induced invasiveness of monocytes.
|
| 9 |
matrix metallopeptidase-9 in tumor tissues
(1 time)
|
Neoplasms
(1 time)
|
EGFR-TKI (1 time)
mTOR (1 time)
NSCLC (1 time)
|
2014 Antitumor activity of selective MEK1/2 inhibitor AZD6244 in combination with PI3K/mTOR inhibitor BEZ235 in gefitinib-resistant NSCLC xenograft models.
|
| 10 |
matrix metalloproteinase-2 and -9
(1 time)
|
Pharmacology
(1 time)
|
BMMs (1 time)
JNK (1 time)
LPS (1 time)
|
2016 Herbacetin inhibits RANKL-mediated osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
|
| 11 |
matrix-degrading metalloproteinase-9
(1 time)
|
Allergy and Immunology
(1 time)
|
RA (1 time)
SF (1 time)
|
1996 Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker.
|
| 12 |
metalloprotease MMP-9
(1 time)
|
Otolaryngology
(1 time)
|
uPA (1 time)
|
1998 An orthotopic floor-of-mouth cancer model allows quantification of tumor invasion.
|
| 13 |
metalloproteinase-1, which subsequently inhibited metalloproteinase-9
(1 time)
|
Biology
(1 time)
|
FBXO22 (1 time)
RCC (1 time)
SCF (1 time)
|
2019 FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis.
|
| 14 |
metalloproteinase-9 in serum
(1 time)
|
Medicine
(1 time)
|
---
|
2006 [Influence of Broncho-Vaxom treatment on serum concentration of metalloproteinase-9 in patients with chronic obstructive pulmonary disease].
|
| 15 |
metalloproteinases in general and specially gelatinase B/metalloproteinase-9
(1 time)
|
Multiple Sclerosis
(1 time)
|
MS (1 time)
|
2017 Multiple sclerosis: Association of gelatinase B/matrix metalloproteinase-9 with risk and clinical course the disease.
|
| 16 |
metastatic propensity, namely, metalloproteinase-9
(1 time)
|
Neoplasms
(1 time)
|
TIMP-2 (1 time)
VEGF (1 time)
|
2001 Expression of metastases-associated genes in cervical cancers resected in the proliferative and secretory phases of the menstrual cycle.
|
| 17 |
microglial markers and metalloproteinase-9
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
2014 Involvement of pro- and antinociceptive factors in minocycline analgesia in rat neuropathic pain model.
|
| 18 |
MMP 92-kDa type IV collagenase
(1 time)
|
Molecular Biology
(1 time)
|
MMP (1 time)
SCC (1 time)
|
1997 Fibroblast-directed expression and localization of 92-kDa type IV collagenase along the tumor-stroma interface in an in vitro three-dimensional model of human squamous cell carcinoma.
|
| 19 |
MMP activity by 490 +/- 30
(1 time)
|
Neurology
(1 time)
|
AVMs (1 time)
MMP (1 time)
sEng (1 time)
|
2009 Soluble endoglin modulates aberrant cerebral vascular remodeling.
|
| 20 |
MMP, metalloproteinase
(1 time)
|
Toxicology
(1 time)
|
AR (1 time)
DBP (1 time)
PIN (1 time)
|
2009 Long-term effects of developmental exposure to di-n-butyl-phthalate (DBP) on rat prostate: proliferative and inflammatory disorders and a possible role of androgens.
|
| 21 |
MMP-9 and NGAL complex
(1 time)
|
Gynecology
(1 time)
|
NGAL (1 time)
|
2019 The levels of matrix metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in different stages of endometriosis.
|
| 22 |
MMP-9 and TIMP-1 complex
(1 time)
|
Neoplasms
(1 time)
|
DFS (1 time)
PLA (1 time)
TIMP-1 (1 time)
|
2013 Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study.
|
| 23 |
MMP-9 and TIMP-1 serum protein levels than healthy controls
(1 time)
|
Medicine
(1 time)
|
COPD (1 time)
TIMP-1 (1 time)
|
2016 Relationships of MMP-9 and TIMP-1 proteins with chronic obstructive pulmonary disease risk: A systematic review and meta-analysis.
|
| 24 |
MMP-9 CD
(1 time)
|
Complementary Therapies
(1 time)
|
alpha-SMA (1 time)
Sal B (1 time)
|
2011 Matrix metalloproteinase-9 induces cardiac fibroblast migration, collagen and cytokine secretion: inhibition by salvianolic acid B from Salvia miltiorrhiza.
|
| 25 |
MMP-9 downregulation
(1 time)
|
Cardiovascular Diseases
(1 time)
|
BMP4 (1 time)
ECM (1 time)
FSS (1 time)
|
2015 Bone morphogenetic protein-4 and transforming growth factor-beta1 mechanisms in acute valvular response to supra-physiologic hemodynamic stresses.
|
| 26 |
MMP-9 expression to the native tissue level
(1 time)
|
Cardiovascular Diseases
(1 time)
|
BMP4 (1 time)
ECM (1 time)
FSS (1 time)
|
2015 Bone morphogenetic protein-4 and transforming growth factor-beta1 mechanisms in acute valvular response to supra-physiologic hemodynamic stresses.
|
| 27 |
MMP-9 knockout
(1 time)
|
Psychiatry
(1 time)
|
CeA (1 time)
|
2017 Matrix Metalloproteinase-9 and Synaptic Plasticity in the Central Amygdala in Control of Alcohol-Seeking Behavior.
|
| 28 |
MMP-9-cells
(1 time)
|
Molecular Biology
(1 time)
|
---
|
2019 MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest.
|
| 29 |
MMP-9/NGAL compared to healthy controls
(1 time)
|
Neoplasms
(1 time)
|
BMI (1 time)
NGAL (1 time)
|
2009 Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.
|
| 30 |
MMP-9PL
(1 time)
|
Radiology
(1 time)
|
AAAs (1 time)
AOD (1 time)
|
2000 Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease.
|
| 31 |
monoclonal antibodies to human M(r) 92,000 type IV collagenase
(1 time)
|
Neoplasms
(1 time)
|
MMPs (1 time)
|
1993 M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.
|
| 32 |
monocyte metalloproteinase-9
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
1997 Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression.
|
| 33 |
monocyte migration and metalloproteinase-9
(1 time)
|
Endocrinology
(1 time)
|
DPP-IV (1 time)
GLP-1 (1 time)
RANTES (1 time)
|
2012 Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe (-/-) mice.
|
| 34 |
morphology; metalloproteinase-9
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
2018 Exocellular extract of Fusarium oxysporum, fungus free, is able to permeate and act selectively in skin.
|
| 35 |
mRNA and protein levels of metalloproteinase-9
(1 time)
|
Complementary Therapies
(1 time)
|
LMPAB (2 times)
AbM (1 time)
|
2009 A low molecular weight polysaccharide isolated from Agaricus blazei Murill (LMPAB) exhibits its anti-metastatic effect by down-regulating metalloproteinase-9 and up-regulating Nm23-H1.
|
| 36 |
MYP3 expressed only a trace amount of 92-kDa gelatinase
(1 time)
|
Neoplasms
(1 time)
|
MMP-2 (1 time)
|
1993 Effect of epidermal growth factor and transforming growth factor beta 1 on growth and invasive potentials of newly established rat bladder carcinoma cell lines.
|
A Search Service for Abbreviation / Long Form